The death toll from a boat carrying Indonesian illegal immigrants that sank off the coast of Pulau Pangkor has risen to nine after another body was recovered. Search and rescue operations are currently underway to locate five individuals who remain missing.
Recovery of Ninth Victim
The Perak branch of the Malaysian Maritime Enforcement Agency (MMEA) confirmed that the body of a male victim was discovered yesterday at approximately 5:31 p.m. The discovery was made by the Royal Malaysian Navy (RMN) asset, KD Sri Indera Sakti.
The body was located 4.5 nautical miles southwest of Pulau Pangkor. Following the recovery, the body was handed over to the Royal Malaysian Navy’s Fast Combat Boat (FCB) 1002 at 6:25 p.m. For further action.
Scale of the Search Operation
The search and rescue (SAR) mission began at 7 a.m. Today, marking the fourth day of operations. Efforts are currently concentrated on the area where victims’ bodies were previously found during the second day of the search.
The operation involves a coordinated effort between air and sea assets from the MMEA, the RMN, and the Marine Police Force (PPM).
Incident Background
The tragedy occurred early last Monday morning when a boat believed to be carrying 37 Indonesian illegal immigrants capsized. The vessel was en route to Malaysia when it sank in the waters off Pulau Pangkor.
While 23 victims have been successfully rescued, the search for the remaining five missing passengers is likely to continue today as authorities exhaust available sectors.
Frequently Asked Questions
How many people were believed to be on the boat?
The boat was believed to be carrying 37 Indonesian illegal immigrants.
How many people have been rescued so far?
A total of 23 victims have been rescued.
Which agencies are involved in the search and rescue mission?
The operation involves assets from the Malaysian Maritime Enforcement Agency (MMEA), the Royal Malaysian Navy (RMN), and the Marine Police Force (PPM).
How should maritime authorities balance rescue efforts with the challenges of searching vast open-water sectors?
Worth a look
- $2.5 Billion to Accelerate the Kingdom’s Strategic Priorities
- 5 Arrested for Alleged Rape of Cape Town E-Hailing Driver
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)